Search results
Showing 166 to 180 of 301 results for breast cancer
Awaiting development [GID-TA11339] Expected publication date: TBC
Microwave ablation for primary or metastatic cancer in the lung (IPG716)
Evidence-based recommendations on microwave ablation for primary or metastatic cancer in the lung in adults. This involves inserting a probe into the lung, through the skin of the chest, to send microwaves into the cancer cells. This produces heat, aiming to destroy the cancer (ablation).
View recommendations for IPG716Show all sections
Pembrolizumab for previously treated metastatic triple negative breast cancer [ID1246]
Discontinued [GID-TA10295]
Awaiting development [GID-TA11110] Expected publication date: TBC
Entinostat for treating hormone receptor-positive breast cancer after hormonal therapy [ID1260]
Discontinued [GID-TA10309]
This guideline covers diagnosis and management of thyroid cancer in people aged 16 and over. It aims to reduce variation in practice and increase the quality of care and survival for people with thyroid cancer.
Triptorelin for the adjuvant treatment of early breast cancer in premenopausal women [ID976]
Discontinued [GID-TA11261]
Osteoporosis: assessing the risk of fragility fracture (CG146)
This guideline covers assessing the risk of fragility fracture in people aged 18 and over with osteoporosis. It aims to provide guidance on the selection and use of risk assessment tools in the care of adults at risk of fragility fractures in all NHS settings.
NICE has developed a medtech innovation briefing (MIB) on AlignRT for intracranial stereotactic radiosurgery .
Neratinib for treating HER2-positive breast cancer after 2 therapies [ID1381]
Discontinued [GID-TA10539]
specialty adviser for medical oncology.Trustee 'It's in the Bag' testicular cancer charity.Member of Sciensus medical advisory...
specialty adviser for medical oncology.Trustee 'It's in the Bag' testicular cancer charity.Member of Sciensus medical advisory...
specialty adviser for medical oncology.Trustee 'It's in the Bag' testicular cancer charity.Member of Sciensus medical advisory...